Dimensional Fund Advisors
EIGR

Dimensional Fund Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Dimensional Fund Advisors’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,494
Closed -$363K – 3529
2023
Q1 		$363K Sell
13,494
-6,722
-33% -$313K ﹤0.01% 3091
2022
Q4 		$716 Sell
20,216
-1,863
-8% -$224K ﹤0.01% 2978
2022
Q3 		$4.99M Buy
22,079
+4,158
+23% +$1.02M ﹤0.01% 2427
2022
Q2 		$3.39M Buy
17,921
+4,995
+39% +$1.01M ﹤0.01% 2578
2022
Q1 		$3.22M Buy
12,926
+3,405
+36% +$538K ﹤0.01% 2678
2021
Q4 		$1.48M Buy
9,521
+2,490
+35% +$482K ﹤0.01% 2929
2021
Q3 		$1.41M Buy
7,031
+775
+12% +$184K ﹤0.01% 2952
2021
Q2 		$1.6M Buy
6,256
+765
+14% +$191K ﹤0.01% 2932
2021
Q1 		$1.46M Buy
5,491
+1,884
+52% +$594K ﹤0.01% 2924
2020
Q4 		$1.33M Buy
3,607
+341
+10% +$97.8K ﹤0.01% 2912
2020
Q3 		$798K Hold
3,266
– – ﹤0.01% 2978
2020
Q2 		$941K Buy
3,266
+723
+28% +$213K ﹤0.01% 2954
2020
Q1 		$519K Buy
2,543
+1,593
+168% +$508K ﹤0.01% 3049
2019
Q4 		$424K Buy
950
+328
+53% +$116K ﹤0.01% 3157
2019
Q3 		$191K Buy
622
+1
+0.2% +$325 ﹤0.01% 3286
2019
Q2 		$198K Hold
621
– – ﹤0.01% 3324
2019
Q1 		$261K Sell
621
-604
-49% -$242K ﹤0.01% 3272
2018
Q4 		$373K Buy
1,225
+687
+128% +$222K ﹤0.01% 3192
2018
Q3 		$194K Buy
+538
New +$184K ﹤0.01% 3317

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Dimensional Fund Advisors's EIGR Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2023, closing a stake of 13,494 shares — an estimated $363K sold.

Dimensional Fund Advisors first reported a position in EIGR in Q3 2018 and held it in 19 quarters. The position peaked at $4.99M in Q3 2022. 66 funds tracked by Wall St. Rank hold EIGR as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 13,494 Eiger BioPharmaceuticals, Inc. shares in Q2 2023, an estimated $363K.
  • Dimensional Fund Advisors first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2018 and held it in 19 quarters.
  • Dimensional Fund Advisors's Eiger BioPharmaceuticals, Inc. position peaked at $4.99M in Q3 2022.
  • 66 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.